Discovery of novel small molecule activators of β-catenin signaling

Area of Science:

• Molecular Biology
• Cell Biology
• Drug Discovery

Background:

• Wnt/β-catenin signaling is vital for embryonic development and adult stem cell maintenance.
• Dysregulation of this pathway is linked to neurodegenerative disorders and bone formation issues.

Purpose of the Study:

• To screen for novel small molecule activators of Wnt/β-catenin signaling.
• To identify compounds that specifically target and modulate this pathway.

Main Methods:

• Utilized a β-galactosidase fragment complementation assay to measure β-catenin nuclear entry.
• Screened a small molecule compound library for Wnt/β-catenin pathway activators.
• Tested compound activity and selectivity across various cell lines, including human osteosarcoma U2OS cells.

Main Results:

• Identified bona fide activators of β-catenin signaling that stabilize cytoplasmic β-catenin and enhance reporter gene activity.
• Demonstrated remarkable cell-type specificity, with compounds activating the pathway only in U2OS cells.
• Ruled out glycogen synthase kinase 3 and Frizzled receptors as direct molecular targets.

Conclusions:

• Differences in cellular Wnt/β-catenin signaling machinery can be leveraged for cell-specific activator discovery.
• The identified compounds represent promising tools for further investigation into Wnt/β-catenin pathway modulation.
• This study opens avenues for developing targeted therapeutics for Wnt/β-catenin-related conditions.